Medical Research
(H20)
IRS Verified
DX Registered
990 on File
NEW YORK STEM CELL FOUNDATION INC
Financial strength (30%)
57/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$30.4M
Total Revenue
$43.5M
Total Expenses
$34.4M
Net Assets
154
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
91.0%
Fundraising Efficiency
2879.5%
Operating Reserve
9.50x
Liability-to-Asset
63.2%
Revenue Diversification
100.0%
Executive Compensation
$795K
Compared with Peers
FY 2023
Compared with 132 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
91.0% | 82.7% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
4.7% | 13.5% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
4.3% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
2879.5% | 639.6% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
9.5 mo | 12.6 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
63.2% | 29.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 91.9% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-19.0% | 7.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
4.2% | 10.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-43.0% | -2.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $30.4M | $43.5M | $34.4M | 91.0% | 154 |
| 2022 | $37.5M | $41.7M | $47.5M | 91.3% | 164 |
| 2021 | $43.6M | $39.7M | N/A | — | 138 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.